# Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

> **NCT01586910** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medtronic Cardiovascular** · enrollment: 1746 (actual)

## Conditions studied

- Severe Aortic Stenosis

## Interventions

- **DEVICE:** Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
- **PROCEDURE:** Surgical Aortic Valve Replacement (SAVR)
- **DEVICE:** Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)

## Key facts

- **NCT ID:** NCT01586910
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-04
- **Primary completion:** 2018-07
- **Final completion:** 2026-11
- **Target enrollment:** 1746 (ACTUAL)
- **Last updated:** 2025-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01586910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01586910, "Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01586910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*